This paper highlights the complex interactions between taste, hormone signals, diet, and weight change, says Alex DiFeliceantonio, PhD, a researcher and an assistant professor in human nutrition, foods, and exercise at Virginia Tech in Blacksburg, Virginia, who was not involved in the study
The new study focused on the impact of taking weight loss drugs in connection with muscle mass and function
Grip strength, walking speed, and functional performance are clinically more meaningful than absolute LBM numbers from a DXA scan
Semaglutide is a GLP-1 receptor agonist, and tirzepatide is a dual agonist at GLP-1 and GIP receptors
The medication itself is only part of the cost
In SURMOUNT-1, 91% lost at least 5%, 79% lost at least 15%, and 36% lost at least 25%